- Home
- GTBP vs LRHC Comparison
GTBP vs LRHC Comparison
Compare GTBP & LRHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GTBP | LRHC |
|---|---|---|
| Founded | 1965 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.1M | 679.5K |
| IPO Year | 2016 | 2022 |
Fundamental Metrics
Financial Performance| Metric | GTBP | LRHC |
|---|---|---|
| Price | $0.42 | $1.08 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 799.3K | ★ 1.3M |
| Earning Date | 01-01-0001 | 04-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 3.75 | ★ 26.17 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $69,448,786.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 118.67 |
| 52 Week Low | $0.40 | $0.08 |
| 52 Week High | $3.73 | $11.21 |
Technical Indicators
Market Signals| Indicator | GTBP | LRHC |
|---|---|---|
| Relative Strength Index (RSI) | 34.51 | 46.27 |
| Support Level | $0.41 | $0.98 |
| Resistance Level | $0.59 | $1.25 |
| Average True Range (ATR) | 0.04 | 0.17 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 6.00 | 23.20 |
Price Performance
Historical ComparisonAbout GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.
About LRHC La Rosa Holdings Corp.
La Rosa Holdings Corp operates in the U.S. residential real estate market. It is a holding company for agent-centric, technology-integrated, cloud-based, multi-service real estate companies. The company's business is organized based on the services it provides internally to the agents and to the public, which are residential and commercial real estate brokerage, franchising, real estate brokerage education and coaching, and property management. The company has six reportable segments, namely: Real Estate Brokerage Services (Residential), Franchising Services, Coaching Services, Property Management, Real Estate Brokerage Services (Commercial), and Title Settlement and Insurance. It derives maximum revenue from the Real Estate Brokerage Services (Residential) segment.